Antoine Papiernik - Jun 28, 2021 Form 4 Insider Report for Shockwave Medical, Inc. (SWAV)

Role: Director, 10%+ Owner
Signature: /s/ Trinh Phung, as attorney-in-fact for Antoine Papiernik
Stock symbol: SWAV
Transactions as of: Jun 28, 2021
Transactions value $: $0
Form type: 4
Date filed: 7/9/2021, 09:42 PM
Previous filing: Jun 1, 2021
Next filing: Mar 11, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SWAV	Common Stock	Award	$0	+850	+31.47%	$0.00	3.55K	Jun 28, 2021	Direct	F1
holding	SWAV	Common Stock						122K	Jun 28, 2021	By Sofinnova Capital VII FCPR	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Reflects shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The shares subject to the restricted stock units vest on 6/25/2022, subject to the Reporting Person's continued service through such date.
F2	Represents shares directly held by Sofinnova Capital VII FCPR, reported by Sofinnova Capital VII FCPR on a separate Form 4. The reporting person is one of the managing partners of Sofinnova Partners SAS, a French corporation and the management company of Sofinnova Capital VII FCPR. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest.

Content

Reflects shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The shares subject to the restricted stock units vest on 6/25/2022, subject to the Reporting Person's continued service through such date.

Represents shares directly held by Sofinnova Capital VII FCPR, reported by Sofinnova Capital VII FCPR on a separate Form 4. The reporting person is one of the managing partners of Sofinnova Partners SAS, a French corporation and the management company of Sofinnova Capital VII FCPR. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest.